drugset
drugset / Trial / NCT00075426

Arsenic Trioxide in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

NCT00075426 ↗

Phase 2 Completed 30 enrolled The University of Texas Medical Branch, Galveston
Open-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy, such as arsenic trioxide, use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: This phase II trial is studying how well arsenic trioxide works in treating patients with locally advanced or metastatic non-small cell lung cancer.

Timeline

Start
2002-11
Primary completion
2005-07
Completion
2005-07

Drugs

EvaluationDrugModalityDoseRoute
Subject arsenic trioxide Small molecule — Intravenous

Indications

lung cancer